BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2015 5:46:00 PM | Browse: 767 | Download: 727
Publication Name World Journal of Hepatology
Manuscript ID 15432
Country/Territory France
2014-11-27 10:56
Peer-Review Started
2014-11-29 12:24
To Make the First Decision
2014-12-12 17:33
Return for Revision
2014-12-18 14:30
2014-12-22 18:29
Second Decision
2015-01-14 08:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-01-20 16:51
Articles in Press
2015-01-20 16:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-04-13 14:20
Publish the Manuscript Online
2015-04-19 17:46
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Virology
Manuscript Type Review
Article Title Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade
Manuscript Source Invited Manuscript
All Author List Heidi Barth
Funding Agency and Grant Number
Corresponding author Dr. Heidi Barth, Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, 3 rue Koeberlé, 67000 Strasbourg, France. heidi.barth@chru-strasbourg.fr
Keywords Pathogenesis; Host genetics; Direct-acting antivirals; Drug resistance; Vaccine; Hepatitis C virus
Core Tip Twenty-five years after the discovery of hepatitis C virus (HCV) as the major cause of non-A, non-B post-transfusion hepatitis, we have entered a new era in HCV treatment that indicates the prospect of eradication of this important human pathogen. In this article, we will discuss the promising opportunities ahead and key future challenges in the era of new hepatitis C treatments, i.e., barriers in identifying HCV infected individuals, access to new HCV drugs, emergence of drug resistance, and the current status of HCV vaccine development.
Publish Date 2015-04-19 17:46
Citation Barth H. Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol 2015; 7(5): 725-737
Url http://www.wjgnet.com/1948-5182/full/v7/i5/725.htm
DOI http://dx.doi.org/10.4254/wjh.v7.i5.725
Full Article (PDF) WJH-7-725.pdf
Full Article (Word) WJH-7-725.doc
Manuscript File 15432-Review.doc
Answering Reviewers 15432 Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 15432-Conflict-of-interest statement.pdf
Copyright License Agreement 15432-Copyright assignment.pdf
Peer-review Report 15432-Peer review(s).pdf
Scientific Misconduct Check 15432-CrossCheck.jpg
Scientific Editor Work List 15432-Scientific editor work list.pdf